3 Regional Jewellery Retailer, Precision Engineered Components Maker and Specialty Chemicals Maker Stocks With a Strong Future Roadmap: PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology
- November 5, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology: ROE of 11.4% to 20.9% and FY22 to FY26 revenue CAGR of 8.5% to 43.0%. Prices as of 4 Nov 2026.
Quick Answer
The three hospital, stock exchange and shrimp stocks to watch are PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology. Their return on equity ranges from 11.4% to 20.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.5% to 43.0%. PN Gadgil Jewellers leads on both return on equity at 20.9% and revenue growth at 43.0% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.
Hospital, stock exchange and shrimp stocks bring together companies with a visible plan for the years ahead. PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology cover a regional jewellery retailer, a precision engineered components maker and a specialty chemicals maker.
This list covers three hospital, stock exchange and shrimp stocks with complete current figures: PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Hospital, Stock Exchange and Shrimp Stocks?
Hospital, stock exchange and shrimp stocks are listed companies that sell gold, silver, diamond and platinum jewellery, make precision components for clean energy, nuclear, space and defence, and produce performance chemicals, pharma intermediates and FMCG chemicals. Their earnings depend on festive buying, strategic programmes and chemical orders.
Hospital, Stock Exchange and Shrimp Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| PN Gadgil Jewellers | 581.6 | 8,435 | 18.9 | 44.2 | 20.9 | 0.89 |
| MTAR Technologies | 6,036.5 | 22,064 | 165.4 | 48.1 | 11.4 | 0.46 |
| Clean Science and Technology | 656.4 | 8,080 | 34.7 | 35.1 | 14.5 | 0.00 |
On valuation, PN Gadgil Jewellers and Clean Science and Technology trade at a P/E below the industry P/E, while MTAR Technologies trades above it, which reflects the growth the market already expects. Readers comparing hospital, stock exchange and shrimp stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Hospital, Stock Exchange and Shrimp Stocks Have a Strong Roadmap in India?
Hospital, stock exchange and shrimp stocks have a strong roadmap in India because wedding and festive buying, rising clean energy and space programmes and wider specialty chemical uses keep widening the market for these companies.
- Jewellery. Weddings and festivals support steady buying.
- Precision components. Clean energy and space programmes need exact parts.
- Specialty chemicals. Own processes serve pharma and consumer makers.
Why PN Gadgil Jewellers Features Among These Hospital, Stock Exchange and Shrimp Stocks
Among the hospital, stock exchange and shrimp stocks on this list, PN Gadgil Jewellers is a Pune-based jewellery retailer with a long history in Maharashtra, selling gold, silver, diamond and platinum jewellery through its own stores and online.
The company has a return on equity of 20.9%, a debt to equity ratio of 0.89 and a market capitalisation of Rs 8,435 crore. The stock trades at a P/E of 18.9, below the industry P/E of 44.2.
Revenue rose from Rs 2,586 crore in FY22 to Rs 10,827 crore in FY26, a compound annual growth rate of 43.0%. Net profit grew from Rs 69.5 crore in FY22 to Rs 410 crore in FY26, which works out to a compound annual growth rate of 55.8%. In the June 2026 quarter, revenue grew 40.3% year on year to Rs 2,423 crore, while net profit rose 51.9% to Rs 105 crore.
Roadmap: The company is opening new stores across Maharashtra and neighbouring states and is widening its range of gold and silver jewellery. A strong regional brand helps it win repeat customers.
What to watch: Monitor store additions, gold price movements and festive season demand.
Why MTAR Technologies Features Among These Hospital, Stock Exchange and Shrimp Stocks
Among the jewellery and engineering shares on this list, MTAR Technologies is a Hyderabad-based maker of precision engineered components and assemblies for clean energy, nuclear, space and defence customers.
Revenue rose from Rs 331 crore in FY22 to Rs 899 crore in FY26, a compound annual growth rate of 28.4%. Net profit grew from Rs 60.9 crore in FY22 to Rs 94.0 crore in FY26, which works out to a compound annual growth rate of 11.5%.
The company has a return on equity of 11.4%, a debt to equity ratio of 0.46 and a market capitalisation of Rs 22,064 crore. The stock trades at a P/E of 165.4, above the industry P/E of 48.1.
Roadmap: The company supplies critical parts for fuel cell systems, space launch vehicles and nuclear power programmes, areas where qualification takes years and customer relationships are long-lasting. Added capacity and a growing order book support future revenue.
What to watch: Check order book execution in clean energy and the ramp-up of newly added capacity.
Why Clean Science and Technology Features Among These Hospital, Stock Exchange and Shrimp Stocks
Among the three companies on this list, Clean Science and Technology makes specialty chemicals including performance chemicals, pharma intermediates and FMCG chemicals using its own catalytic processes.
In the June 2026 quarter, revenue grew 13.4% year on year to Rs 291 crore, while net profit rose 4.7% to Rs 73.3 crore. Revenue rose from Rs 715 crore in FY22 to Rs 989 crore in FY26, a compound annual growth rate of 8.5%.
Net profit for FY26 was Rs 230 crore, a net margin of 23.2%. The company has a return on equity of 14.5%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 8,080 crore. The stock trades at a P/E of 34.7, below the industry P/E of 35.1.
Roadmap: The company uses cleaner, in-house developed processes that give it cost advantages in products such as MEHQ and guaiacol. It is adding new products and capacity, and carries no debt.
What to watch: Watch new product launches and capacity utilisation at its newer plants.
PN Gadgil Jewellers vs MTAR Technologies vs Clean Science and Technology on Key Financials
The table below sets the three hospital, stock exchange and shrimp stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| PN Gadgil Jewellers | 2,586 | 10,827 | 43.0% | 410 | 3.8% |
| MTAR Technologies | 331 | 899 | 28.4% | 94.0 | 10.5% |
| Clean Science and Technology | 715 | 989 | 8.5% | 230 | 23.2% |
PN Gadgil Jewellers posts the highest return on equity in this group at 20.9%. PN Gadgil Jewellers combines the largest FY26 revenue at Rs 10,827 crore with the fastest revenue growth, a 43.0% compound annual rate. A useful habit with hospital, stock exchange and shrimp stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Hospital, Stock Exchange and Shrimp Stocks
Every theme carries risks that deserve a check before any decision. For these hospital, stock exchange and shrimp stocks, the main points are: Long-term jewellery and engineering shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Consumer spending. Sales follow festivals, incomes and consumer mood.
- Order timing. Defence and space orders can shift between periods.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter hospital, stock exchange and shrimp stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Hospital, Stock Exchange and Shrimp Stocks
Hospital, stock exchange and shrimp stocks suit investors who prefer to study business strength before price moves. PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology each have a clear plan to grow. Based on the 4 November 2026 close, PN Gadgil Jewellers trades at Rs 581.6, MTAR Technologies at Rs 6,036.5 and Clean Science and Technology at Rs 656.4. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these hospital, stock exchange and shrimp stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track hospital, stock exchange and shrimp stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are hospital, stock exchange and shrimp stocks?
Ans. Hospital, stock exchange and shrimp stocks are listed companies that sell gold, silver, diamond and platinum jewellery, make precision components for clean energy, nuclear, space and defence, and produce performance chemicals, pharma intermediates and FMCG chemicals. Their earnings depend on festive buying, strategic programmes and chemical orders. This list looks at three of them, PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.
Which hospital, stock exchange and shrimp stocks are covered in this list?
Ans. This list covers PN Gadgil Jewellers, MTAR Technologies and Clean Science and Technology. Based on the 4 November 2026 close, PN Gadgil Jewellers traded at Rs 581.6, MTAR Technologies at Rs 6,036.5 and Clean Science and Technology at Rs 656.4. Their return on equity ranges from 11.4% to 20.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.5% to 43.0%.
Why do hospital, stock exchange and shrimp stocks have a strong future roadmap in India?
Ans. Hospital, stock exchange and shrimp stocks have a strong roadmap in India because wedding and festive buying, rising clean energy and space programmes and wider specialty chemical uses keep widening the market for these companies. The main drivers are as follows. Jewellery. Weddings and festivals support steady buying. Precision components. Clean energy and space programmes need exact parts. Specialty chemicals. Own processes serve pharma and consumer makers. Together these factors give the companies on this list a visible path for growth over the coming years.
How has PN Gadgil Jewellers performed financially?
Ans. Revenue rose from Rs 2,586 crore in FY22 to Rs 10,827 crore in FY26, a compound annual growth rate of 43.0%. Net profit grew from Rs 69.5 crore in FY22 to Rs 410 crore in FY26, which works out to a compound annual growth rate of 55.8%. In the June 2026 quarter, revenue grew 40.3% year on year to Rs 2,423 crore, while net profit rose 51.9% to Rs 105 crore. The company has a return on equity of 20.9%, a debt to equity ratio of 0.89 and a market capitalisation of Rs 8,435 crore. The stock trades at a P/E of 18.9, below the industry P/E of 44.2. Looking ahead, the company is opening new stores across Maharashtra and neighbouring states and is widening its range of gold and silver jewellery. A strong regional brand helps it win repeat customers.
How has MTAR Technologies performed financially?
Ans. Revenue rose from Rs 331 crore in FY22 to Rs 899 crore in FY26, a compound annual growth rate of 28.4%. Net profit grew from Rs 60.9 crore in FY22 to Rs 94.0 crore in FY26, which works out to a compound annual growth rate of 11.5%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.46 and a market capitalisation of Rs 22,064 crore. The stock trades at a P/E of 165.4, above the industry P/E of 48.1. Looking ahead, the company supplies critical parts for fuel cell systems, space launch vehicles and nuclear power programmes, areas where qualification takes years and customer relationships are long-lasting. Added capacity and a growing order book support future revenue.
How has Clean Science and Technology performed financially?
Ans. Revenue rose from Rs 715 crore in FY22 to Rs 989 crore in FY26, a compound annual growth rate of 8.5%. Net profit for FY26 was Rs 230 crore, a net margin of 23.2%. In the June 2026 quarter, revenue grew 13.4% year on year to Rs 291 crore, while net profit rose 4.7% to Rs 73.3 crore. The company has a return on equity of 14.5%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 8,080 crore. The stock trades at a P/E of 34.7, below the industry P/E of 35.1. Looking ahead, the company uses cleaner, in-house developed processes that give it cost advantages in products such as MEHQ and guaiacol. It is adding new products and capacity, and carries no debt.
What risks should investors check before buying hospital, stock exchange and shrimp stocks?
Ans. Investors should check a few risks before buying hospital, stock exchange and shrimp stocks. Consumer spending. Sales follow festivals, incomes and consumer mood. Order timing. Defence and space orders can shift between periods. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of hospital, stock exchange and shrimp stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.